Himanshu Suri
Pain Medicine · Hallandale Beach, FLNPI 1073977328
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $25,486 with a category attached, or 78.5%. 22 manufacturers reported payments, led by Boston Scientific at 47.7% of the total. Reporting peaked in 2021 at $21,452 and has fallen 91.0% since, to $1,924 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $203.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$12K
- Medtronic$10K
- Nalu Medical, Inc.$783
- Nevro Corp.$384
- Scilex Pharmaceuticals Inc.$347
- SPR Therapeutics, Inc$222
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$470%
- Grants$20,00078%
- Food & beverage$5,43921%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 28 | $12,162 |
| Medtronic | 5 | $10,332 |
| Nalu Medical, Inc. | 19 | $783 |
| Nevro Corp. | 6 | $384 |
| Scilex Pharmaceuticals Inc. | 19 | $347 |
| SPR Therapeutics, Inc | 2 | $222 |
| Abbott | 3 | $220 |
| AbbVie(2 entities) | 9 | $176 |
| Merz North America, Inc. | 1 | $133 |
| Forte Bio-pharma LLC | 7 | $122 |
| Vertos Medical, Inc. | 1 | $112 |
| Spinal Simplicity, LLC | 3 | $106 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Amneal Pharmaceuticals LLC | 3 | $57 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| Pfizer | 2 | $49 |
| Acorda Therapeutics, Inc | 3 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WAVEWRITER ALPHA$10,161
- SYNCHROMED$10,000
- Intracept$641
- Nalu Neurostimulation System$362
- WaveWriter Alpha Prime 16$295
- SPECTRA WAVEWRITER$292
- Omnia$227
- Proclaim IPG$153
- INTELLIS$146
- XEOMIN$133
- INTELLIS ADAPTIVESTIM$131
- SPRINT PNS System$127
- Senza$121
- mild Device Kit$112
How this compares
$25,486 in reported general payments places this provider in the 90th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZtlidoLidocaine | 17 | $15,387 |
| Xtampza ErOxycodone Myristate | 15 | $15,190 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 258 | $8,404 |
| MovantikNaloxegol Oxalate | 15 | $7,589 |
| Lidocaine | 19 | $2,110 |
| Fentanyl | 13 | $2,070 |
| Oxycodone Hcl | 73 | $1,674 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $1,447 |
| Diclofenac Sodium | 32 | $1,355 |
| Gabapentin | 84 | $802 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $699 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $683 |
| Pregabalin | 28 | $549 |
| Methocarbamol | 18 | $243 |
| Tizanidine Hcl | 25 | $231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Ztlido | $347 | $15,38717 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $64 | $15,19015 claims |
| Redhill Biopharma Inc.Movantik | $17 | $7,58915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Hallandale Beach
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.